DJIA 17,969.31 256.65 1.45%
NASDAQ 4,926.28 35.06 0.72%
S&P 500 2,081.82 20.80 1.01%
market minute promo

Peregrine Pharmaceuticals (NASDAQ: PPHM)

1.39 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PPHM $1.39 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.38
Previous Close $1.39
Daily Range $1.38 - $1.40
52-Week Range $1.19 - $2.09
Market Cap $260.8M
P/E Ratio -4.78
Dividend (Yield) $0.00 (0.0%)
Volume 160,903
Average Daily Volume 1,493,647
Current FY EPS -$0.30

Sector

Healthcare

Industry

Drug Makers

Peregrine Pharmaceuticals (PPHM) Description

A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases. Website: http://www.peregrineinc.com/

News & Commentary

Why Peregrine Pharmaceuticals Tacked on 10% in February

Peregrine Pharmaceuticals ushers in a double-digit percentage gain in February after releasing new preclinical trial data. Here's what investors need to know.

Skip Peregrine Pharmaceuticals For 2015

Peregrine Pharmaceuticals' (PPHM) CEO Steve King on Q3 2015 Results - Earnings Call Transcript

Peregrine Pharmaceuticals (PPHM) Stock Gains on Revenue Beat

Peregrine Pharmaceuticals (PPHM) Q3 2015 Results - Earnings Call Webcast

Earnings Reaction History: Peregrine Pharmaceuticals Corporation, 42.9% Follow-Through Indicator, 6.

Earnings Reaction History: Peregrine Pharmaceuticals Corporation, 42.9% Follow-Through Indicator, 6.1% Sensitive

Peregrine Pharmaceuticals (PPHM) Highlighted As Weak On High Volume

Wall Street's Current Play: 'Immunotherapy Of Cancer'

IHUB Most Posted And Most Read Stocks Do Not Perform Well

Morning Market Gainers

See More PPHM News...

PPHM's Top Competitors

PPHM $1.39 (0.00%)
Current stock: PPHM
AMGN $163.57 (0.60%)
Current stock: AMGN
GILD $99.97 (-1.02%)
Current stock: GILD
BIIB $432.07 (0.51%)
Current stock: BIIB